Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report-Reference-Cited by-同舟云学术

Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report

Author:

Bidadi Behzad¹²,Watson Andrea³^ORCID,Weigel Brenda⁴,Oliveira Andre⁵,Kirkham Justin⁶^ORCID,Arndt Carola⁷

Affiliation:

1. Merck Pharmaceuticals North Wales Pennsylvania

2. Division of Pediatric Hematology/Oncology, Department of Pediatric and Adolescent MedicineMayo Clinic Rochester Minnesota

3. Division of Pediatric Hematology/Oncology, Department of OncologyEssentia Health Duluth Clinic Duluth Minnesota

4. Division of Pediatric Hematology and Oncology, Department of PediatricsUniversity of Minnesota Minneapolis Minnesota

5. Department of Laboratory Medicine and PathologyMayo Clinic Rochester Minnesota

6. Department of Pediatric and Adolescent MedicineMayo Clinic Rochester Minnesota

7. Division of Pediatric Hematology/OncologyDepartment of Pediatric and Adolescent MedicineMayo Clinic Rochester Minnesota

Funder

Mayo Clinic Children's Research Center

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

Reference20 articles.

1. Infantile myofibromatosis and the use of magnetic‐resonance imaging;Wiswell TE;Am J Dis Child,1988

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献